急性肠系膜缺血实施血管内优先策略治疗后的长期结局
该回顾性队列纳入2009至2013年连续66例动脉闭塞性急性肠系膜缺血患者,50例尝试血管内血运重建(EVR+),16例未尝试血运重建(EVR-)。EVR技术成功44例(88%),全组30天死亡率44%;EVR+组30天死亡率32% vs EVR-组81%,1年生存率52% vs 19%,5年生存率18% vs 13%。
要点
- EVR技术成功44例(88%),3例EVR失败后转开放血运重建
- 30天死亡率EVR+组32% vs EVR-组81%
- 幸存者中仅2例永久入住机构,其余出院回原居住地
核心结论
- 在未经筛选的老年急性肠系膜缺血人群中,积极尝试EVR的策略带来高血运重建率和良好结局。
- 存活患者中高比例恢复既往居住状态且再入院率低,鼓励对高功能状态老年患者积极治疗。
研究设计与样本
- 回顾性研究队列,纳入2009至2013年间连续66例(全纳入)因动脉闭塞性急性肠系膜缺血治疗的患者。
- 50例尝试血管内血运重建(EVR+),16例未尝试血运重建(EVR-)。
- 所有患者随访至死亡或2022年9月。
主要发现
- 全部66例平均年龄78 ± 10岁:EVR+组79 ± 9岁,EVR-组76 ± 12岁。
- EVR技术成功44例(88%);3例EVR失败后接受后续开放血运重建;三分之一患者EVR后需肠切除。
- 全部患者30天死亡率为44%;EVR+组32% vs EVR-组81%。
- 仅2例幸存者永久入住机构,其余均出院回急性肠系膜缺血发作前居住地;随访期间4例急性肠系膜缺血相关再入院,均在EVR+组;2例因复发急性肠系膜缺血接受再干预。
- 1年生存率EVR+组52% vs EVR-组19%;5年生存率分别为18%和13%;死亡原因:肠系膜缺血22例、其他心血管事件21例、非心血管原因19例;随访结束时4例存活。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the rationale of an aggressive endovascular-first strategy to treat elderly patients with acute mesenteric ischemia (AMI) by studying long-term survival, readmissions, and patients' discharge to home vs nursing facility a decade after an episode of AMI. METHODS: The retrospective study cohort included 66 consecutive patients (all-comers) treated for arterial occlusive AMI between 2009 and 2013. Endovascular revascularization (EVR) was attempted in 50 patients (EVR+), whereas 16 patients were treated without attempted revascularization (EVR-). All patients were followed until death or September 2022. Studied outcomes included discharge status, long-term survival and cause of death and readmissions related to AMI. RESULTS: The mean age of all 66 patients was 78 ± 10 years: 79 ± 9 years in the EVR+ group and 76 ± 12 years in the EVR- group. EVR was technically successful in 44 patients (88%); three patients underwent subsequent open revascularization after EVR failure. One-third required bowel resection after EVR. The 30-day mortality for all patients was 44%; 32% in the EVR+ group and 81% in the EVR- group. Only two survivors were permanently institutionalized, whereas all others were discharged to the same place they lived prior to the AMI episode. There were four AMI-related readmissions during the follow-up; all were in the EVR+ group. Two patients underwent reinterventions for recurrent AMI. One-year survival was 52% for EVR+ and 19% for EVR- patients. Five-year survival rates were 18% and 13%, respectively. The causes of deaths were mesenteric ischemia in 22, other cardiovascular event in 21, and non-cardiovascular cause in 19 patients. Four patients were alive at the end of the follow-up. CONCLUSIONS: In this unselected elderly population with AMI, the aggressive strategy to attempt EVR resulted in a high revascularization rate and favorable outcomes. The high proportion of patients returning to their prior living status and low readmission rate after survival from AMI encourages active treatment of high-functioning elderly patients.
引用
- Pengermä P, Venesmaa S, Karjalainen J, et al. Long-term outcome after implementation of endovascular-first strategy to treat acute mesenteric ischemia. J Vasc Surg. 2023. PMID: 37586616. doi:10.1016/j.jvs.2023.08.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。